Resultados globales: 8 registros encontrados en 0.01 segundos.
Artículos, Encontrados 8 registros
Artículos Encontrados 8 registros  
1.
7 p, 1.3 MB Increased Presentation of Diabetic Ketoacidosis and Changes in Age and Month of Type 1 Diabetes at Onset during the COVID-19 Pandemic in Spain / Leiva-Gea, Isabel (Instituto de Investigación Biomédica de Málaga) ; Antúnez Fernández, Cristina (Hospital Punta de Europa) ; Cardona-Hernandez, Roque (Hospital Sant Joan de Déu (Manresa)) ; Ferrer Lozano, Marta (Hospital Universitario Miguel Servet (Saragossa)) ; Bahíllo-Curieses, Pilar (Hospital Clínico Universitario de Valladolid) ; Arroyo-Díez, Javier (Hospital Universitario Materno Infantil de Badajoz) ; Clemente León, María (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martín-Frías, Maria (Hospital Universitario Ramón y Cajal (Madrid)) ; Conde Barreiro, Santiago (Centro de Salud de Barbastro) ; Mingorance Delgado, Andrés (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Pérez Sánchez, Jacobo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Universitat Autònoma de Barcelona
To assess the impact of the COVID-19 pandemic and lockdown measures on the presenting characteristics (age at diagnosis, severity, monthly distribution) of newly diagnosed type 1 diabetes in Spanish children. [...]
2022 - 10.3390/jcm11154338
Journal of clinical medicine, Vol. 11 (july 2022)  
2.
27 p, 6.2 MB Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes : miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion / Gómez Muñoz, Laia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Perna-Barrull, David (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Murillo-Vallés, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Armengol, Maria Pilar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Alcalde, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Català, Martí (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Rodríguez-Fernández, Silvia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sunye, Sergi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Valls, Aina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pérez Sánchez, Jacobo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Corripio, Raquel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Vives Pi, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
The partial remission (PR) phase of type 1 diabetes (T1D) is an underexplored period characterized by endogenous insulin production and downmodulated autoimmunity. To comprehend the mechanisms behind this transitory phase and develop precision medicine strategies, biomarker discovery and patient stratification are unmet needs. [...]
2023 - 10.3390/ncrna9020017
Non-Coding RNA, Vol. 9 (february 2023)  
3.
23 p, 12.1 MB Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes / Gómez Muñoz, Laia (Institut Germans Trias i Pujol) ; Perna-Barrull, David (Institut Germans Trias i Pujol) ; Caroz-Armayones, Josep M. (The Johns Hopkins University - Pompeu Fabra University Public Policy Center) ; Murillo-Vallés, Marta (Institut Germans Trias i Pujol) ; Rodríguez-Fernández, Silvia (Institut Germans Trias i Pujol) ; Valls, Aina (Institut Germans Trias i Pujol) ; Vázquez, Federico (Institut Germans Trias i Pujol) ; Pérez Sánchez, Jacobo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Corripio, Raquel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Castaño, Luis (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Bel, Joan (Institut Germans Trias i Pujol) ; Vives Pi, Marta (Institut Germans Trias i Pujol)
The partial remission (PR) phase, a period experienced by most patients with type 1 diabetes (T1D) soon after diagnosis, is characterized by low insulin requirements and improved glycemic control. Given the great potential of this phase as a therapeutic window for immunotherapies because of its association with immunoregulatory mechanisms and β-cell protection, our objective was to find peripheral immunological biomarkers for its better characterization, monitoring, and prediction. [...]
2022 - 10.3389/fimmu.2022.825426
Frontiers in immunology, Vol. 13 (february 2022)  
4.
14 p, 1.8 MB NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes / Gómez Muñoz, Laia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Perna-Barrull, David (Institut Germans Trias i Pujol) ; Villalba Felipe, Adrián (Institut Germans Trias i Pujol) ; Rodríguez-Fernández, Silvia (Institut Germans Trias i Pujol) ; Ampudia Carrasco, Rosa María (Institut Germans Trias i Pujol) ; Teniente Serra, Aina (Institut Germans Trias i Pujol) ; Vázquez, Federico (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Murillo-Vallés, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pérez Sánchez, Jacobo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Corripio, Raquel (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Bel, Joan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Vives Pi, Marta (Institut Germans Trias i Pujol)
Type 1 diabetes (T1D) is a chronic metabolic disease characterized by the autoimmune destruction of β-cells in the pancreatic islets. T1D is preceded by islet-specific inflammation led by several immune cells. [...]
2021 - 10.3389/fimmu.2020.611522
Frontiers in immunology, Vol. 11, art. 611522 (january 2021)  
5.
16 p, 6.7 MB Mutations in HID1 Cause Syndromic Infantile Encephalopathy and Hypopituitarism / Schänzer, Anne (Institute of Neuropathology, Justus-Liebig-University, Giessen, Germany) ; Achleitner, Melanie T. (University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria) ; Trümbach, Dietrich (Institute of Metabolism and Cell Death, Helmholtz Center, Munich, Germany) ; Hubert, Laurence (Inserm UMR1163, Imagine Institute, Tanslational Genetics, Université de Paris, Paris, France) ; Munnich, Arnold (Inserm UMR1163, Imagine Institute, Tanslational Genetics, Université de Paris, Paris, France) ; Ahlemeyer, Barbara (Institute for Anatomy and Cell Biology, Division of Medical Cell Biology, Justus Liebig University, Giessen, Germany) ; AlAbdulrahim, Maha M. (King Abdullah Bin Abdulaziz University Hospital, Riyadh, Saudi Arabia) ; Greif, Philipp A. (Experimental Leukemia and Lymphoma Research Department of Medicine III, University Hospital, LMU Munich, Munich, Germany) ; Vosberg, Sebastian (German Cancer Research Centre (DKFZ), Heidelberg, Germany) ; Hummer, Blake (Molecular and Cellular Biophysics Program, Department of Biological Sciences, University of Denver, Denver, CO, USA) ; Feichtinger, René G. (University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria) ; Mayr, Johannes A. (University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria) ; Wortmann, Saskia B. (Radboud Center for Mitochondrial Medicine, Department of Pediatrics, Amalia Children's Hospital, Radboudumc, Nijmegen, The Netherlands) ; Aichner, Heidi (Department of Pediatrics, Academic Teaching Hospital, Landeskrankenhaus Feldkirch, Feldkirch, Austria) ; Rudnik-Schöneborn, Sabine (Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria) ; Ruiz, Anna (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Gabau, Elisabeth (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Pérez Sánchez, Jacobo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Ellard, Sian (College of Medicine and Health, University of Exeter, Exeter, UK) ; Homfray, Tessa (Saint George's University Hospital and Royal Brompton Hospital, London, UK) ; Stals, Karen L. (Genomic Laboratory, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK) ; Wurst, Wolfgang (Ludwig-Maximilians-Universität München) ; Neubauer, Bernd A. (Department of Child Neurology, Justus-Liebig-University, Giessen, Germany) ; Acker, Till (Institute of Neuropathology, Justus-Liebig-University, Giessen, Germany) ; Bohlander, Stefan K. (Leukaemia and Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand) ; Asensio, Cédric (Molecular and Cellular Biophysics Program, Department of Biological Sciences, University of Denver, Denver, CO, USA) ; Besmond, Claude (Inserm UMR1163, Imagine Institute, Tanslational Genetics, Université de Paris, Paris, France) ; Alkuraya, Fowzan S. (Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia) ; AlSayed, Moenaldeen D. (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Hahn, Andreas (Department of Child Neurology, Justus-Liebig-University, Giessen, Germany) ; Weber, Axel (Institute of Human Genetics, Justus-Liebig- University, Giessen, Germany) ; Universitat Autònoma de Barcelona
Precursors of peptide hormones undergo posttranslational modifications within the trans-Golgi network (TGN). Dysfunction of proteins involved at different steps of this process cause several complex syndromes affecting the central nervous system (CNS). [...]
2021 - 10.1002/ana.26127
Annals of neurology, Vol. 90 (june 2021) , p. 143-158  
6.
11 p, 746.0 KB Safety Outcomes During Pediatric GH Therapy : Final Results From the Prospective GeNeSIS Observational Program / Child, Christopher J. (Eli Lilly and Company, Windlesham, Surrey, United Kingdom) ; Zimmermann, Alan G. (Eli Lilly and Company, Indianapolis, Indiana) ; Chrousos, George P. (National and Kapodistrian University of Athens, School of Medicine, Athens, Greece) ; Cummings, Elisabeth (Dalhousie University/IWK Health Centre, Halifax, Nova Scotia, Canada) ; Deal, Cheri L. (University of Montreal and CHU Ste-Justine, Montreal, Quebec, Canada) ; Hasegawa, Tomonobu (Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan) ; Jia, Nan (Eli Lilly and Company, Indianapolis, Indiana) ; Lawrence, Sarah (Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada) ; Linglart, Agnès (Hôpital Bicêtre Paris Sud, Paris, France) ; Loche, Sandro (Ospedale Pediatrico Microcitemico "A. Cao," AO Brotzu, Cagliari, Italy) ; Maghnie, Mohamad (Istituto Giannina Gaslini, University of Genova, Genoa, Italy) ; Pérez Sánchez, Jacobo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Polak, Michel (Hôpital Universitaire Necker Enfants Malades and Université Paris Descartes, Centre des Maladies Endocrines Rares de la Croissance, Paris, France) ; Predieri, Barbara (University of Modena and Reggio Emilia, Modena, Italy) ; Richter-Unruh, Annette (University Children's Hospital, Bochum, Germany) ; Rosenfeld, Ron G. (Oregon Health and Science University, Portland, Oregon) ; Yeste Fernández, Diego (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Yorifuji, Tohru (Osaka City General Hospital, Miyakojima-ku, Osaka, Japan) ; Blum, Werner F.. (University of Giessen, Giessen, Germany) ; Universitat Autònoma de Barcelona
Safety concerns have been raised regarding premature mortality, diabetes, neoplasia, and cerebrovascular disease in association with GH therapy. To assess incidence of key safety outcomes. Prospective, multinational, observational study (1999 to 2015). [...]
2018 - 10.1210/jc.2018-01189
The journal of clinical endocrinology & metabolism, Vol. 104 (september 2018) , p. 379-389  
7.
14 p, 127.3 KB Measurement properties of the online EuroQol-5D-youth instrument in children and adolescents with type 1 diabetes mellitus : Questionnaire study / Mayoral, K.. (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Rajmil, Luis (Agència de Qualitat i Avaluació Sanitàries de Catalunya) ; Murillo-Vallés, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Garin, Olatz (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Pont, A. (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Alonso, Jordi (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Bel, Joan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pérez Sánchez, Jacobo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Corripio, Raquel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Carreras, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Herrero Espinet, Francisco Javier (Corporació de Salut del Maresme i la Selva. Hospital de Calella) ; Mengibar, J. M. (Corporació de Salut del Maresme i la Selva. Hospital de Blanes) ; Rodríguez Arjona, Dolors (Agència de Qualitat i Avaluació Sanitàries de Catalunya) ; Ravens-Sieberer, Ulrike (Department of Child and Adolescent Psychiatry. Psychotherapy. and Psychosomatics. University Medical Center Hamburg - Eppendorf) ; Raat, Hein (Department of Public Health. Erasmus University Medical Center Rotterdam) ; Serra-Sutton, V. (Agència de Qualitat i Avaluació Sanitàries de Catalunya) ; Ferrer, M. (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública)
Background: The lack of continuity between health-related quality of life (HRQoL) instruments designed for children and adults hinders change analysis with a life course approach. To resolve this gap, EuroQol (EQ) developed the EQ-5D-Youth (EQ-5D-Y), derived from the EQ-5D for adults. [...]
2019 - 10.2196/14947
Journal of medical Internet research, Vol. 21 Núm. 11 (2019) , p. e14947  
8.
9 p, 402.7 KB Health-related quality of life (HRQOL) and its associated factors in children with Type 1 Diabetes Mellitus (T1DM) / Murillo-Vallés, Marta (Universitat Autònoma de Barcelona) ; Bel, Joan (Universitat Autònoma de Barcelona) ; Pérez Sánchez, Jacobo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Corripio, Raquel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Carreras, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Herrero, Xavier (Corporació de Salut del Maresme i la Selva) ; Mengibar, Josep-Maria (Corporació de Salut del Maresme i la Selva) ; Rodríguez Arjona, Dolors (Agència de Qualitat i Avaluació Sanitàries de Catalunya) ; Ravens-Sieberer, Ulrike (Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg- Eppendorf, Germany) ; Raat, Hein (Department of Public Health, Erasmus MC - University Medical Center Rotterdam, The Netherlands) ; Rajmil, Luis (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Universitat Autònoma de Barcelona
The objective of the study was to describe the baseline health-related quality of life (HRQOL) in a cohort of children and adolescents with type 1 diabetes mellitus (T1DM), and analyze its associated clinical and sociodemographic factors, assessing HRQOL through internet. [...]
2017 - 10.1186/s12887-017-0788-x
BMC Pediatrics, Vol. 17 (january 2017)  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.